• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute, 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2017

Pages:70

File Size:1 file , 2.9 MB

Note:This product is unavailable in Russia, Belarus

This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI standard pdf

CLSI EP26-Ed2-IG

CLSI EP26-Ed2-IG

User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide, EP26-Ed2-IG

$25.00 $50.00

CLSI M57S

CLSI M57S

Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th Edition, M57SEd4

$40.00 $80.00

CLSI M27M44S

CLSI M27M44S

Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd Edition, M27M44S

$40.00 $80.00

CLSI M38M51S

CLSI M38M51S

Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi, 3rd Edition, M38M51SEd3

$40.00 $80.00